Form D · Other Health Care
BioCeryx Inc.
Menlo Park, CA · CIK 0001732405
Offering snapshot reported Feb 23, 2018 · SEC filing
- Reported sold
- $5M Offering amount: $15M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 5, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 23, 2018 | Initial | $5,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-306262
Source: Form D, filed Feb 23, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Paul Balog | Director, Executive |
| Michael Downing | Director |
| Manish Kothari | Director |
| Amit Kumar | Director, Executive |
| Song Liu | Director |
| Jonas Lauren Norr | Director |
| Raymond Tong | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
C/O Bio Ceryx Inc. 333 Ravenswood Avenue
Menlo Park, CA, 94025
Menlo Park, CA, 94025